Two MS Medications Appear on FDA’s Shame List
Two multiple sclerosis medications that are both popular and expensive are on a new “shame list” that U.S. regulators hope will increase price competition. The medications are Ampyra (dalfampridine), made by Acorda, and Tecfidera (dimethyl fumarate), by Biogen. They’re included on a list of more than 50 medications whose manufacturers, according to the Food and Drug Administration, are putting obstacles in front of companies that want to create cheaper, generic versions.…Continue Reading
